Vascular disease, hypertension, and prevention: "From endothelium to clinical events"

Journal of the American College of Cardiology

Volumn 42, Issue 2, 2003, Pages 377-379

  Hirsch, Alan T ^a  

^a UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

C REACTIVE PROTEIN; CELL ADHESION MOLECULE; INTERCELLULAR ADHESION MOLECULE 1; INTERLEUKIN 6; PLASMINOGEN ACTIVATOR INHIBITOR 1;

ATHEROSCLEROSIS; CARDIOVASCULAR RISK; CLINICAL TRIAL; CONFERENCE PAPER; ENDOTHELIUM; HUMAN; HYPERTENSION; INFLAMMATION; METABOLIC SYNDROME X; PRIORITY JOURNAL; RISK FACTOR; VASCULAR DISEASE;

EID: 0038826197     PISSN: 07351097     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0735-1097(03)00747-2     Document Type: Conference Paper

References (6)

1. Mora S, Blumenthal RS, Yanek LR, Moy TF, Becker LC, Becker DM. Elevated C-reactive protein in high-risk asymptomatic individuals is strongly associated with the metabolic syndrome (abstr). J Am Coll Cardiol 2003;41 Suppl A:292A.
2. Albert MA, Glynn RJ, Ridker PM. Plasma concentration of C-reactive protein and physical activity (abstr). J Am Coll Cardiol 2003;41 Suppl A:319A.
3. Preis O, Beckman JA, Rifai N, Ridker PM. The relationship between severity of peripheral arterial disease and markers of inflammation (abstr). J Am Coll Cardiol 2003;41 Suppl A:317A.
4. Hongo Y, Hassan A, Sudhir K, et al. Incidence and characteristics of ruptured plaque in femoro-popliteal arteries (abstr). J Am Coll Cardiol 2003;41 Suppl A:303A.
5. L'Italien GJ, Ford I, Shepherd J. The metabolic syndrome is an independent risk factor of cardiac events in WOSCOPS males (abstr). J Am Coll Cardiol 2003;41 Suppl A:291A.
6. Cohen JD, Eberly LB, Prineas R, Vasquez G, & MRFIT group. The Influence of the metabolic syndrome on 24-year mortality among middle-aged men in the Multiple Risk Factor Intervention Trial (MRFIT) (abstr). J Am Coll Cardiol 2003;41 Suppl A:291.